Loading clinical trials...
Loading clinical trials...
A Randomized, Double-blind, Placebo-controlled, Single and Multiple Ascending Dose, Phase 1 Clinical Trial to Evaluate Pharmacokinetics, Pharmacodynamics, Safety and Tolerability After Oral Administration of AJH-2947 in Healthy Korean or Caucasian Male Subjects
Conditions
Interventions
AJH-2947 100 mg (SAD)
Placebo
+16 more
Locations
1
South Korea
Seoul National University Hospital
Seoul, South Korea
Start Date
December 5, 2023
Primary Completion Date
April 1, 2025
Completion Date
September 1, 2025
Last Updated
October 17, 2024
NCT07231419
NCT06614322
NCT05986292
NCT07260656
NCT07057128
NCT07493226
Lead Sponsor
JMackem Co., Ltd
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions